1. Home
  2. AI vs OGN Comparison

AI vs OGN Comparison

Compare AI & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C3.ai Inc.

AI

C3.ai Inc.

N/A

Current Price

$9.68

Market Cap

1.4B

Sector

Technology

ML Signal

N/A

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.75

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AI
OGN
Founded
2009
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
AI
OGN
Price
$9.68
$13.75
Analyst Decision
Hold
Hold
Analyst Count
14
5
Target Price
$14.00
$11.40
AVG Volume (30 Days)
4.5M
2.6M
Earning Date
05-27-2026
05-07-2026
Dividend Yield
N/A
0.60%
EPS Growth
N/A
N/A
EPS
N/A
0.95
Revenue
$250,268,000.00
$6,216,000,000.00
Revenue This Year
N/A
$0.45
Revenue Next Year
N/A
$1.67
P/E Ratio
N/A
$14.47
Revenue Growth
N/A
N/A
52 Week Low
$7.68
$5.69
52 Week High
$20.22
$13.76

Technical Indicators

Market Signals
Indicator
AI
OGN
Relative Strength Index (RSI) 54.03 72.40
Support Level $9.81 $13.46
Resistance Level $10.73 N/A
Average True Range (ATR) 0.42 0.04
MACD -0.00 0.00
Stochastic Oscillator 40.96 93.18

Price Performance

Historical Comparison
AI
OGN

About AI C3.ai Inc.

C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions, namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications; C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications; and C3 Generative AI, which combines the utility of large language models. Geographically, the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: